Franke Molly F, Jerome J Gregory, Matias Wilfredo R, Ternier Ralph, Hilaire Isabelle J, Harris Jason B, Ivers Louise C
Department of Global Health and Social Medicine, Harvard Medical School, Boston, MA, USA.
Zanmi Lasante/Partners In Health, Port au Prince, Haiti.
Vaccine. 2017 Oct 13;35(43):5819-5827. doi: 10.1016/j.vaccine.2017.09.025. Epub 2017 Sep 12.
Case-control studies to quantify oral cholera vaccine effectiveness (VE) often rely on neighbors without diarrhea as community controls. Test-negative controls can be easily recruited and may minimize bias due to differential health-seeking behavior and recall. We compared VE estimates derived from community and test-negative controls and conducted bias-indicator analyses to assess potential bias with community controls.
From October 2012 through November 2016, patients with acute watery diarrhea were recruited from cholera treatment centers in rural Haiti. Cholera cases had a positive stool culture. Non-cholera diarrhea cases (test-negative controls and non-cholera diarrhea cases for bias-indicator analyses) had a negative culture and rapid test. Up to four community controls were matched to diarrhea cases by age group, time, and neighborhood.
Primary analyses included 181 cholera cases, 157 non-cholera diarrhea cases, 716 VE community controls and 625 bias-indicator community controls. VE for self-reported vaccination with two doses was consistent across the two control groups, with statistically significant VE estimates ranging from 72 to 74%. Sensitivity analyses revealed similar, though somewhat attenuated estimates for self-reported two dose VE. Bias-indicator estimates were consistently less than one, with VE estimates ranging from 19 to 43%, some of which were statistically significant.
OCV estimates from case-control analyses using community and test-negative controls were similar. While bias-indicator analyses suggested possible over-estimation of VE estimates using community controls, test-negative analyses suggested this bias, if present, was minimal. Test-negative controls can be a valid low-cost and time-efficient alternative to community controls for OCV effectiveness estimation and may be especially relevant in emergency situations.
量化口服霍乱疫苗效力(VE)的病例对照研究通常将无腹泻的邻居作为社区对照。检测阴性对照易于招募,并且可能将因不同的求医行为和回忆偏倚降至最低。我们比较了来自社区对照和检测阴性对照的VE估计值,并进行了偏倚指标分析,以评估使用社区对照时的潜在偏倚。
2012年10月至2016年11月,从海地农村的霍乱治疗中心招募急性水样腹泻患者。霍乱病例粪便培养呈阳性。非霍乱腹泻病例(用于偏倚指标分析的检测阴性对照和非霍乱腹泻病例)培养和快速检测均为阴性。按年龄组、时间和邻里将多达4名社区对照与腹泻病例进行匹配。
主要分析纳入181例霍乱病例、157例非霍乱腹泻病例、716名VE社区对照和625名偏倚指标社区对照。两个对照组中自我报告接种两剂疫苗的VE一致,VE估计值具有统计学意义,范围为72%至74%。敏感性分析显示,自我报告两剂VE的估计值相似,但有所减弱。偏倚指标估计值始终小于1,VE估计值范围为19%至43%,其中一些具有统计学意义。
使用社区对照和检测阴性对照进行病例对照分析得出的口服霍乱疫苗(OCV)估计值相似。虽然偏倚指标分析表明使用社区对照可能高估了VE估计值,但检测阴性分析表明,即使存在这种偏倚,其程度也很小。对于OCV效力评估,检测阴性对照可以作为社区对照的一种有效的低成本且省时的替代方法,在紧急情况下可能尤其适用。